S. Boquist

发表

The plasminogen activator inhibitor‐1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study

M. Margaglione, S. Humphries, E. Hawe, 2003, Journal of thrombosis and haemostasis : JTH.

A Common Functional Polymorphism (C→A Substitution at Position −863) in the Promoter Region of the Tumour Necrosis Factor-α (TNF-α) Gene Associated With Reduced Circulating Levels of TNF-α

A. Hamsten, P. Eriksson, F. V. Hooft, 1999 .

A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha.

A. Hamsten, P. Eriksson, F. V. van’t Hooft, 1999, Human molecular genetics.

Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.

A. Hamsten, A. Silveira, U. de Faire, 2012, Thrombosis research.

Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction

J. Odeberg, A. Hamsten, A. Silveira, 2005, Journal of internal medicine.

A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution.

K. Schenck-Gustafsson, A. Hamsten, K. Gertow, 2003, Atherosclerosis.

Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction

A. Hamsten, A. Silveira, P. Eriksson, 2005, Thrombosis and Haemostasis.

Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men.

A. Hamsten, P. Eriksson, U. de Faire, 2002, European heart journal.

Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides.

A. Hamsten, U. de Faire, F. Karpe, 2001, Journal of lipid research.

Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease.

J. Björkegren, A. Hamsten, A. Samnegård, 2000, Circulation.

Structural β-cell Changes and Transient Hyperglycemia in Mice Treated With Compounds Inducing Inhibited Citric Acid Cycle Enzyme Activity

L. Boquist, S. Boquist, I. Ericsson, 1988, Diabetes.

VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia

A. Hamsten, A. Silveira, O. McLeod, 2018, International journal of laboratory hematology.

Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men

A. Hamsten, F. Karpe, G. Ruotolo, 2000, Diabetologia.

Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk

A. Hamsten, F. Karpe, M. Hellénius, 1998 .

Postprandial Enrichment of Remnant Lipoproteins With ApoC-I in Healthy Normolipidemic Men With Early Asymptomatic Atherosclerosis

J. Björkegren, A. Hamsten, A. Silveira, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Correlation of serum IGF‐I and IGFBP‐1 and ‐3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle‐aged men

J. Björkegren, A. Hamsten, U. de Faire, 2008, Clinical endocrinology.

Human Evidence That the Apolipoprotein A-II Gene Is Implicated in Visceral Fat Accumulation and Metabolism of Triglyceride-Rich Lipoproteins

A. Hamsten, U. de Faire, G. Ruotolo, 2001, Circulation.

A high-fat meal is accompanied by increased plasma interleukin-6 concentrations.

C. Held, A. Hamsten, A. Silveira, 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.

J. Björkegren, A. Hamsten, U. de Faire, 1999, Circulation.

A Common Polymorphism in the Promoter Region of the TNFSF4 Gene Is Associated with Lower Allele-Specific Expression and Risk of Myocardial Infarction

A. Hamsten, P. Eriksson, A. Samnegård, 2011, PloS one.

Human genetic evidence that OX40 is implicated in myocardial infarction.

A. Hamsten, P. Eriksson, J. Lagercrantz, 2006, Biochemical and biophysical research communications.

Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.

A. Hamsten, F. Karpe, S. Boquist, 2002, Atherosclerosis.

Mitochondrial changes and associated alterations induced in mice by streptozotocin administered in vivo and in vitro.

L. Boquist, S. Boquist, U. Alehagen, 1987, Diabetes research and clinical practice.

Human Evidence That the Cystatin C Gene Is Implicated in Focal Progression of Coronary Artery Disease

L. Hansson, A. Hamsten, P. Eriksson, 2004, Arteriosclerosis, thrombosis, and vascular biology.

The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.

J. Björkegren, A. Hamsten, A. Silveira, 2005, Journal of the American College of Cardiology.

A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein.

L. Hansson, A. Hamsten, H. Watkins, 2005, Atherosclerosis.

Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome.

A. Hamsten, K. Gertow, M. Bellanda, 2004, The Journal of clinical endocrinology and metabolism.